INTRODUCTION
Foot-and-mouth disease (FMD) remains one of the most economically important diseases of farm animals. It can affect a wide range of cloven-hoofed animal species (including cattle, pigs and sheep) and is able to spread rapidly . The disease is widespread across the world, especially in Africa and Asia. In addition, there are occasional incursions into countries that are normally disease-free, e.g. in the UK in 2001, and these cause very high economic losses. The disease is caused by foot-and-mouth disease virus (FMDV), which is the prototype member of the genus Aphthovirus within the family Picornaviridae. The virus particle comprises a positive-sense ssRNA genome of about 8.4 kb enclosed within a protein shell consisting of 60 copies of each of the four capsid proteins 1A (VP4), 1B (VP2), 1C (VP3) and 1D (VP1) (see Belsham, 2005) . Only VP1, VP2 and VP3 are exposed on the outer surface of the virus particle and, thus, these three proteins determine both the antigenicity of the virus and its ability to interact with receptors on cells.
The virus exists in seven distinct serotypes, O, A, C, SAT1, SAT2, SAT3 and Asia-1. Infection or vaccination against one serotype does not confer protection against other serotypes. There is also significant diversity within serotypes. Serotype O is the most common on a global basis, and serotype A is also widespread. The threedimensional structures of several different serotypes of FMDV have been determined (Acharya et al., 1989; Lea et al., 1994; Curry et al., 1996; Fry et al., 2005) .
The major cellular receptor for FMDV is the integrin avb6, which is expressed on the surface of epithelial cells (Jackson et al., 2000; Monaghan et al., 2005) . Other RGD-binding integrins (e.g. avb8 and avb3) have also been shown to act as functional receptors for FMDV (Jackson et al., 2004; O'Donnell et al., 2009) . The avb6 and avb8 receptors recognize a highly conserved RGDLXXL motif within the VP1 protein (Burman et al., 2006) . In addition, cellculture-adapted serotype O viruses can also bind heparan sulfate (HS) and use this interaction to enter cells. This switch in receptor usage is associated with specific amino acid substitutions on the surface of the virus. The presence of an Arg56 residue in VP3 within cell-culture-adapted viruses greatly enhances the interaction with HS compared with the presence of His56 in VP3 of field strains (Jackson et al., 1996; Fry et al., 1999) . The HS-binding phenotype has been linked to attenuation of a serotype O virus in cattle (Sa-Carvalho et al., 1997) . An ability to bind HS has also been observed for cell-culture-adapted serotype C viruses (Baranowski et al., 2000; Escarmís et al., 1998) , serotype A viruses (Fry et al., 2005) and SAT-type viruses (Maree et al., 2010) . However, it is not yet clear whether all serotypes of FMDV can use HS as an alternative functional cell receptor.
Full-length infectious cDNAs corresponding to the FMDV genome derived from serotype O (Zibert et al., 1990; Falk et al., 1992; Ellard et al., 1999) , serotype A (Rieder et al., 1993; Piccone et al., 1995) and serotype C (García-Arriaza et al., 2004) viruses have been described. In addition, some chimeric FMDV full-length cDNAs have been produced by transferring the capsid coding sequences from one virus serotype into the 'backbone' of a different virus serotype; as expected, the rescued viruses display the antigenicity of the capsid sequences (e.g. Sa-Carvalho et al., 1997; Baranowski et al., 1998; van Rensburg et al., 2004) . The plasmids containing the O1Kaufbeuren cDNA (as used by Zibert et al., 1990; Falk et al., 1992) and the more recent version (pT7S3) developed by Ellard et al. (1999) are based on a cell-culture-adapted B64 strain of the O1 Kaufbeuren virus (O1K B64).
To the best of our knowledge, no studies have been reported previously that have examined the ability of viruses rescued from O1K B64-derived infectious cDNA to cause disease in natural host animals. It is now shown that the rescued O1K B64 virus is highly attenuated in cattle. However, two chimeric virus derivatives, containing surface-exposed capsid proteins from field strains of 
RESULTS
Rescue and characterization of FMDV from chimeric cDNA plasmids Plasmids containing the full-length FMDV O1K B64 cDNA (pT7S3; Ellard et al., 1999) plus modified versions including the O-UKG capsid region (O1K/O-UKG chimera) and the A-TUR capsid region (O1K/A-TUR chimera), as well as a modified O1K B64 plasmid (pT7S3-NheI) containing an engineered restriction site used for swapping the capsid sequences, were prepared (Fig. 1) . Each plasmid was linearized and the DNAs were then used as templates for the production of full-length FMDV RNAs in vitro. These transcripts were then introduced into BHK cells by electroporation. The treated cells alone, or overlaid onto monolayers of pBTY or ZZ-R 127 cells, were incubated for 24 h and then, in each case, passed once more on fresh monolayers of the same cell type. In BHK cells, the O1K B64 virus and its slightly modified derivative, O1K B64Nhe (from pT7S3-NheI), each grew efficiently, and extensive cytopathic effect (CPE) was observed in both the first and second passages (Table 1 ). The chimeric transcript containing the A-TUR capsid coding region also induced extensive CPE in electroporated BHK cells, but the CPE in the second passage in these cells was incomplete. Finally, the O1K/O-UKG chimera produced extensive CPE in electroporated cells but grew very poorly in the second passage in BHK cells. In contrast, the rescued parental O1K B64 virus plus the two chimeric viruses containing the capsid coding sequences from 'field' strains of FMDV all grew well in both pBTY cells and the ZZ-R 127 goat cell line and produced complete CPE in each case (Table 1) . These results are consistent with the fact that the O1K B64 cDNA is derived from a BHK-celladapted virus (and hence may be expected to grow well in BHK cells), while the 'field' virus capsid regions (especially the serotype O sequence) seem to confer reduced ability to grow in BHK cells (which may lack an appropriate RGDbinding integrin).
To explore the properties of these viruses in more detail, growth curves for the O1K B64 virus and the two chimeric viruses were determined in both BHK cells and pBTY cells (Fig. 2) . Almost identical growth kinetics were observed for each virus in pBTY cells (Fig. 2a) , whereas production of the O1K/O-UKG chimera was reduced significantly in BHK cells compared with the rescued O1K B64 virus, while the growth of the O1K/A-TUR chimera was intermediate (Fig. 2b) .
The rescued FMDVs were analysed using serotype-specific FMDV antigen ELISAs. As anticipated, the O1K B64 and O1K/O-UKG viruses were each identified as serotype O, while the O1K/A-TUR chimeric virus was identified as serotype A (Table 1) .
Pathogenicity of FMDV O1K B64 and its chimeric derivatives in cattle
Previous studies by Sa-Carvalho et al. (1997) showed that an HS-binding virus (O1-Campos) is attenuated in cattle and therefore the O1K B64 virus, which also displays high affinity for HS (Fry et al., 1999) , could also be attenuated. To determine the pathogenicity of the O1K B64 virus and its derivatives in cattle, experiments were performed in which the O1K B64, O1K/O-UKG and O1K/A-TUR viruses (each grown in pBTY cells) were inoculated into the tongues of calves that were then kept in contact with other calves for a period of 10 days. Clinical examination of the calves was performed on a daily basis and serum samples were collected to determine viraemia [as measured by quantitative real-time RT-PCR (qRT-PCR) assays] and the generation of anti-FMDV antibodies (as determined in serotype-specific blocking ELISAs).
(i) O1K/O-UKG chimeric virus. In the first experiment, two calves (3C3 and 3C5) were inoculated (on day 0) in the tongue with the O1K/O-UKG virus and were each kept in contact with two other calves (3C3 with 3C1 plus 3C2 and 3C5 with 3C4 plus 3C6) within two adjacent pens. On day 2 post-inoculation (p.i.), calf 3C3 exhibited standard clinical signs of FMD, including elevated temperature (41 u C) with moderate salivation and the presence of vesicles both at the site of inoculation and elsewhere in the mouth and a single, unruptured vesicle on the left hind foot (posterior face in interdigital space). These clinical signs developed further on day 3 (except the temperature, which decreased) but subsequently moderated, and the lesions started to heal on subsequent days. No significant signs of disease were apparent in the other inoculated calf, 3C5, at this early time point. However, the in-contact calves 3C1, 3C2, 3C4 and 3C6, together with the inoculated calf 3C5, all showed an elevated temperature (above 40 u C) for 1 or 2 days between days 5 and 7 p.i., and all displayed some other signs of clinical disease, including salivation plus lesions in the mouth and on the feet, which were apparent from about day 5 p.i. Thus, the disease had spread from the inoculated animal(s) (presumably 3C3) to the incontact animals and also probably to 3C5. The level of virus in sera reached high levels in most of the animals (up to 1.5610 9 genomes ml 21 in 3C6), but high levels of viral RNA were only detected in the serum for 2 or 3 days in each calf (Fig. 3b) , and no significant viraemia was detected in calf 3C5. Analysis of sera from these animals showed the early presence of anti-FMDV antibodies (from day 5 p.i.) in calf 3C3 and a later positive reaction in each of the other animals, which reached the diagnostic threshold between days 8 and 10 p.i. (Fig. 3c) . Titres of anti-FMDV antibodies were determined for sera scored as positive in the screening assay ( Table 2 ). The decline in viraemia coincided well with the appearance of circulating anti-FMDV antibodies, e.g. in Fig. 1 . Structure of O1K B64 cDNA and its derivatives. The structure of plasmid pT7S3 (Ellard et al., 1999) containing the fulllength cDNA of the O1K B64 strain is shown. Modifications to this plasmid to introduce cDNA fragments corresponding to the coding sequence of the surface-exposed capsid proteins 1B (VP2), 1C (VP3) and 1D (VP1) derived from the O-UKG and A-TUR strains using the NheI and ApaI restriction enzyme sites (as indicated) are described in Methods. The locations of restriction sites used for modifications to the plasmid (see text) are indicated as follows: Ap, ApaI; Kp, KpnI; Sa, SalI; Su, SunI; Xb, XbaI. The full-length plasmids were linearized using HpaI and RNA transcripts were prepared using T7 RNA polymerase. The transcripts were then introduced into cells (see Methods) to rescue the viruses. calf 3C3, antibodies were detected from day 5 and the viraemia, which had reached 2.8610 8 genomes ml 21 at day 2 p.i., had decreased greatly at this time (Fig. 3b, c) . These results showed that the O1K/O-UKG chimeric virus is pathogenic in cattle and can spread from one animal to another.
(ii) O1K B64 virus. Since clear clinical signs of FMD were initially observed only in one of the two calves inoculated with the O1K/O-UKG virus, it was decided to inoculate four calves in subsequent experiments (with just two incontact animals as indicators of virus transmission). This was thought to be particularly appropriate for the O1K B64 virus, since it is tissue-culture-adapted and, as indicated above, previous studies with a similarly cell-cultureadapted serotype O virus indicated that it was attenuated in cattle (Sa-Carvalho et al., 1997) . Indeed, the rescued O1K B64 virus proved to be non-pathogenic in cattle, as none of the four inoculated calves or the two in-contact animals showed clear signs of clinical disease; no significant temperature rise was observed (Fig. 4a) and no lesions were detected. Analysis of sera showed only very low levels of viraemia (,2000 genome copies ml 21 , compared with up to 1.5610 9 genomes ml 21 observed with the O1K/O-UKG chimeric virus) (Fig. 4b ) in just two (4C2 and 4C4) of the inoculated calves, and no viral RNA was detected in sera from the other inoculated animals or their contacts (Fig.  4b) . Furthermore, none of the animals seroconverted against FMDV by day 11 p.i. (Fig. 4c) . Thus, the virus derived from the parental O1K B64 cDNA plasmid pT7S3 (Ellard et al., 1999) was highly attenuated for cattle.
(iii) O1K/A-TUR virus. The chimeric O1K/A-TUR virus was also inoculated into four calves (5C1, 5C2, 5C4 and 5C5) and these were kept in contact with two others (5C3 and 5C6). Three of the animals showed a slight, transient temperature response (Fig. 5a) , and the inoculated animals each displayed drooling from days 1-2 p.i., with the formation of vesicles on the tongue and around the mouth in three of the four animals. In addition, the same three inoculated calves (5C2, 5C4 and 5C5) developed lesions on the feet from days 4 to 8 p.i. The in-contact calf 5C6 developed clinical signs on day 8 of the experiment, including elevated temperature plus lesions on the dental pad and on all four feet by the end of the experiment (day 10). No significant clinical signs were observed in calf 5C3 at any time. Analysis of sera from the animals showed a significant viraemia (up to 4610 7 genomes ml
21
) in all four inoculated animals (5C1, 5C2, 5C4 and 5C5), although it was rather lower in 5C1 (peak of 2610 4 genomes ml 21 ), from days 1-4 p.i., while the in-contact calf 5C6 had high levels of virus (peaking at 8610 6 genomes ml
) in serum on days 7-9 p.i. (Fig. 5b) . No viraemia was detected in the second in-contact calf, 5C3. Consistent with these results, anti-FMDV antibodies (in a serotype A-specific blocking ELISA) became detectable by day 5 p.i. in each of the inoculated animals and at day 10 p.i. in calf 5C6 (Fig. 5c ), but no seroconversion occurred in calf 5C3. High titres of anti-FMDV (serotype A) antibodies were generated in each of the inoculated calves (Table 3) ; the lowest titre was observed in calf 5C1, which also had the lowest level of viraemia (Fig. 5b) . It is clear from these observations that the O1K/A-TUR chimera is also pathogenic in cattle, but the disease was relatively mild and the level of viraemia observed was much lower than that observed with the O1K/O-UKG virus (compare Figs  3b and 5b) . Furthermore, the disease spread from the inoculated calves to only one of the two in-contact animals.
DISCUSSION
The ability to rescue FMDV from plasmids containing the full-length cDNA is well documented; however, the analysis of viruses derived from the O1K B64 full-length cDNA (e.g. pT7S3; Ellard et al., 1999) has been restricted to assays within cell culture (Zibert et al., 1990; Falk et al., 1992; Ellard et al., 1999; Nayak et al., 2006; Zunszain et al., 2010) . The studies presented here demonstrate that, in cattle, the rescued O1K B64 virus is highly attenuated, and it failed to evoke an immune response (Fig. 4) . This is . At the times shown, medium was removed, RLT buffer was added and the samples were frozen prior to RNA extraction. FMDV RNA was quantified in triplicate using a real-time RT-PCR assay as described in Methods. Numbers of FMDV genomes (means±SD; note many of the error bars are too small to see) were calculated with reference to a dilution series of viral RNA transcripts. (Table 2) .
probably due to cell-culture adaptation of the parental virus strain (64 passages) resulting in its ability to bind HS (Fry et al., 1999) , which may promote clearance from the circulation. Previously, Sa-Carvalho et al. (1997) reported that an HS-binding, cell-culture-adapted virus with the capsid proteins of O1-Campos was also attenuated in the two cattle tested. However, reversion to a virulent form of the virus was observed in those animals; no such reversion was apparent with the O1K B64 virus used here.
Substitution of the coding sequences for the surfaceexposed capsid proteins from 'field' strains of FMDV, using sequences derived from either O/UKG/01 or A/TUR/ 06, enabled viable chimeric viruses to be produced. The O1K/O-UKG and O1K/A-TUR viruses displayed the expected antigenicity, corresponding to the inserted capsid sequences. The O1K/O-UKG virus showed a marked preference for growth in pBTY cells compared with BHK cells, whereas the rescued O1K B64 virus grew well in both cell types and O1K/A-TUR showed intermediate properties. Furthermore, the chimeric viruses each proved to be pathogenic in cattle, producing clinical signs typical of FMD, and also spread from inoculated animals to incontact animals.
The O1K/A-TUR virus appeared to induce a higher titre of anti-FMDV antibodies than the O1K/O-UKG virus, even though the latter virus reached a higher level within the circulation. It is likely that this reflects different sensitivities of the serotype-specific assays. It is also apparent that not all animals were susceptible to the O1K/A-TUR virus. Calf 5C3 failed to exhibit any signs of infection and showed no viraemia or immune response against FMDV despite close contact for several days with other calves infected with the O1K/A-TUR virus. It would be interesting to compare the characteristics of this chimera in cattle in parallel with those of the parental A/Turkey 2/2006 virus, but this has not yet been done.
These chimeric cDNA plasmids provide a background for specific modifications of the virus to alter its characteristics in a defined manner. It has been established that viable, but defective, FMDVs can be generated with deletions in various different parts of the genome, for example, within the Leader coding sequence (Piccone et al., 1995) , 3A (Pacheco et al., 2003) and 3B1-3 (Falk et al., 1992) . The effect of such changes on virus pathogenicity can also be examined. In addition, these viruses provide a system for analysis of receptor utilization by different serotypes of FMDV in vivo. Finally, these studies indicate that the multiple passages of the O1K B64 strain of FMDV in cell culture did not result in any adaptations, outside the capsid coding region, that blocked the ability of the virus to cause disease in cattle. as recommended by the manufacturer. For each virus, single-stranded cDNA was generated from the RNA using a primer (59-CGTC-AGAGAAGAAGAAGGGCCCAGGGTTGGACTC-39) that spans the junction of the 2A/2B coding regions and includes an ApaI site (underlined). PCR products for the capsid coding sequences of O-UKG and A-TUR were generated from these templates using the primer used for cDNA synthesis plus separate, strain-specific primers (O-UKG, 59-CGCTCTGCTAGCTGACAAGAAAACCGAGGAGACC-39; A-TUR, 59-CGCTCTGCTAGCTGACAAAAAGACAGAGGAGA-CT-39) that span the junction of the VP4 and VP2 coding regions and include an NheI site (underlined). The introduction of the NheI and ApaI sites in the PCR primers did not change the encoded amino acid sequences.
METHODS
Construction of plasmids containing chimeric full-length FMDV cDNAs. Plasmid pT7S3 (Ellard et al., 1999) contains the full-length cDNA for the O1K B64 strain of FMDV. Chimeric plasmids were generated in which the coding regions for VP2 (1B), VP3 (1C), VP1 (1D) and 2A from the O1K B64 strain were replaced by the corresponding coding sequences of O-UKG or A-TUR generated as described above (Fig. 1) . This was achieved as follows. pT7S3 was digested with KpnI and the~1.4 kbp fragment was Table 2 . Reciprocal titres of anti-FMDV antibodies (serotype O) in sera from calves inoculated on day 0 with chimeric O1K/O-UKG virus and from in-contact calves Sera were collected on a daily basis and those found to be positive in the screening assay (at 1 : 10 dilution; see Fig. 3 ) were reassayed, using 2-fold dilutions, to determine the titre. inserted into pGEM7zf (Promega) to make pGEM7zfDFMDV, which was used as a template for overlap PCRs to introduce an NheI site into the coding region for VP4 using primer 59-CTTCTTGTCG GCTAGCAGAGCGCCGAAA-39 and the complementary 59-TTTC-GGCGCTCTGCTAGCCGACAAGAA together with external primers in the 59-UTR (59-GATTTCCATGCTGGCATTTT-39) and the coding Fig. 4 . Cell-culture-adapted O1K B64 virus is attenuated in cattle. Four bull calves (4C1, 4C2, 4C4 and 4C5, underlined) were inoculated into the tongue with 10 6 TCID 50 of the rescued O1K B64 virus and each pair of calves was housed in contact with one other calf and in adjacent pens. (a) Temperatures and clinical signs (as described in Fig. 3 ) in all six animals were monitored on a daily basis (note that the temperature of calf 4C1 was variable prior to inoculation, and the elevated temperature seen on day 1 p.i. was not considered significant). (b, c) Blood samples were also collected as indicated and the serum was assayed for the presence of FMDV RNA by qRT-PCR (b) and for anti-FMDV antibodies in a serotype O-specific blocking ELISA (c). The number of FMDV genomes was calculated with reference to a dilution series of RNA transcripts as for Fig. 2 (Table 3) .
sequence of VP2 (59-GAAGTGTTCGGTCCGCTCAC-39). The final PCR product was digested with SunI and SalI and the 380 bp fragment, including the NheI site, was used to replace the corresponding SunI-SalI fragment of pGEM7zfDFMDV to generate pGEM7zfDFMDV-NheI. This plasmid was digested with KpnI and the 1.4 kbp fragment was used to replace the corresponding fragment of pT7S3 to generate pT7S3-NheI. Plasmid pT7S3-NheI was then digested with XbaI and the~5 kb fragment, which extends from the 59-UTR to the coding region for 3A, was ligated into XbaIdigested pGEM9zf (Promega) to generate pGEM9zfDFMDV. PCR products containing the capsid coding sequence for the O-UKG and A-TUR viruses (described above) were digested with NheI and ApaI and inserted into similarly digested pGEM9zfDFMDV. The cDNA corresponding to the VP3 capsid coding region of O-UKG includes an NheI site and thus this insertion was performed in two steps. The resulting plasmids contained cDNA corresponding to the coding region for VP2 through to the 2A/2B junction for O-UKG and A-TUR. These plasmids were digested with XbaI and the~5 kb fragments were ligated back into the XbaI-digested backbone of pT7S3 to generate pT7S3/O-UKG and pT7S3/A-TUR, respectively. These plasmids were then sequenced to confirm their structures (Fig. 1) .
Rescue of virus from full-length cDNA plasmids. The parental plasmids and chimeric derivatives were linearized by digestion with HpaI and full-length RNA transcripts were made with T7 RNA polymerase using an Ambion Megascript kit as described by the manufacturer. The RNAs were checked using agarose gel electrophoresis and then introduced into BHK cells by electroporation, essentially as described previously (Nayak et al., 2006) . Electroporated BHK cells were incubated for 24 h either alone or after being overlaid onto fresh monolayers of pBTY cells or the goat epithelial cell line ZZ-R 127 (Brehm et al., 2009 ) and were harvested following freezing. In each case, a second passage (P2) of the virus onto the same cells was performed and the appearance of CPE was monitored. Rescued viruses were characterized using serotype-specific antigen ELISAs for both serotype O and serotype A, essentially as described previously (Roeder & Le Blanc Smith, 1987) .
Virus titres for each virus grown in pBTY cells were determined in fresh pBTY cells as TCID 50 as described previously (Reed & Muench, 1938) .
Virus growth kinetics were determined in both BHK and pBTY cells from the production of FMDV RNA, within cells (in six-well plates) infected with pBTY.P2 virus stocks of the rescued viruses, as measured by qRT-PCR on triplicate samples, as described previously (Reid et al., 2003; Belsham & Normann, 2008 Three similar experiments were performed to determine the pathogenicity of FMDVs recovered from the O1K B64 cDNA and the chimeric derivatives. In each case, male calves (approx. 200 kg) (two for O1K/O-UKG and four for O1K B64 and O1K/A-TUR) were inoculated into the tongue, at two sites, with approx. 10 6 TCID 50 (in total, as determined in pBTY cells) of pBTY.P2 stocks of each FMDV. Each inoculated animal was kept in contact with two other calves in a pen within high-containment animal accommodation and all six animals (in two adjacent pens within a single stable) in each experiment were monitored on a daily basis for signs of clinical disease (including elevated rectal temperature, drooling and appearance of vesicles in the mouth and on the feet) for a period of 10 days. Serum samples were collected before and after inoculation of the animals, on a daily basis, until euthanasia. RNA was then extracted from these samples and assayed for the presence of FMDV RNA by qRT-PCR as described above. The level of viral RNA detected in serum samples was converted to the number of genome copies by reference to a standard curve of reference RNA samples assayed in parallel. Serum samples were also screened for the presence of anti-FMDV antibodies (using a 1 : 10 dilution of serum) using serotype-specific blocking ELISA systems (for O and A as appropriate) as described previously (Have & Jensen, 1983; Balinda et al., 2009 ), and positive samples were then titrated, using 2-fold dilutions, to quantify the antibody content (as in Balinda et al., 2009) . Table 3 . Reciprocal titres of anti-FMDV antibodies (serotype A) in sera from calves inoculated on day 0 with chimeric O1K/A-TUR virus and from in-contact calves Sera were collected from calves on the days indicated and those found to be positive in the screening assay (at 1 : 10 dilution; Fig. 5 ) were reassayed, using 2-fold dilutions, to determine the titre. 
